Tsukamoto S, Kobayashi K, Toyoda M, Tone A, et al. Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease. Diabetes Obes Metab 2024 May 19. doi: 10.1111/dom.15652.
PMID: 38764356